RGEN

Conviction 72HealthcareScan · Tue, Sep 8, 2026

Gravestone doji

RGEN$168.51+0.54%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 1.1M

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

REPLIGEN CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.repligen.com ↗

Price168.51

Change+0.54%

Gap+0.43%

Rel volume0.91×

Avg volume983.78K

Avg $ vol171.35M

SMA 20173.47

SMA 50156.06

SMA 200142.05

Price vs 50+7.97%

Price vs 200+18.63%

MA stackbullish

50/200 cross—

Supertrendup · 160.59

RSI (14)51

MACD hist-2.38

MACD crossbear · 5d

Stoch %K / %D15 / 16

ADX (14)47

+DI / −DI23 / 14

RSI divergence—

MACD divergence—

ATR %+4.37%

ADR %3.98%

52w high182.03

52w low102.87

From 52w high-7.43%

Above 52w low+63.81%

New 52w highNo

SqueezeOff

Bollinger width14.65%

%B0.30

Donchian pos27.03%

Donchian high188.73

Donchian low161.02

AVWAP (52w high)176.62

vs AVWAP high-4.59%

AVWAP (52w low)141.79

vs AVWAP low+18.84%

OBV trendUp

Chaikin MF (20)0.09

Today vs 20d0.91×

Avg vol (14d)1.1M

Avg vol (20d)983.78K

Avg $ vol (20d)171.35M

Market cap9.51B

RS 3m (vs SPY)+32.60%

RS 6m (vs SPY)+25.13%

RS line new highNo

Trend template6/8

Technical rank80.7

1 week-6.89%

1 month+2.81%

3 months+34.45%

6 months+31.76%

1 year+35.28%

YTD+2.53%

P/E194.50

P/B4.50

P/S67.33

P/FCF101.28

EPS0.8600

Div yield—

ROE2.31%

ROA1.66%

Debt/Eq0.26

Current9.05

EV/EBITDA70.60

Gross margin42.83%

Net margin34.62%

Rev growth35.10%

EPS growth291.64%

Price target179.67

Target upside6.62%

Analyst ratingBuy

Institutional127.11%

Ent. value9.45B

Revenue44.83M

Net income5.01M

Gross profit—

Free cash flow93.9M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out56.41M

Employees2K

ListedTue, Apr 29, 1986

Free float55.93M

Float %99.2%

Short interest6.09M

Days to cover6.4d

Short volume61.6%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.54 vs $0.45

Last surprise+20.0% beat

Setup gradeB

Conviction72 / 100

Pattern quality—

Tech rank80.7 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 10
1 scan
→
Breaking out now
Jun 11
1 scan
→
Setting up
Jun 12 – Jun 15
2 scans
→
Breaking out now
Jun 16
1 scan
→
Setting up
Aug 31
1 scan

Congress activity

Disclosed STOCK Act trades in RGEN · 6 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Lisa McClain house · MI · traded 2025-10-30	Sell	$1K–$15K	2025-10-30	2025-11-01	PDF
Lisa McClain house · MI · traded 2025-10-31	Sell	$1K–$15K	2025-10-31	2025-11-01	PDF
Lisa McClain house · R · MI · traded 2025-06-17	Sell	$1K–$15K	2025-06-17	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-07-22	Buy	$1K–$15K	2025-07-22	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-06-11	Buy	$1K–$15K	2025-06-11	2025-08-13	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Sell	$15K–$50K	2025-04-07	2025-05-08	PDF

Insider activity

SEC Form 4 transactions in RGEN · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Hughes Violetta CHIEF ACCOUNTING OFFICER · Common Stock · 2026-09-01	Tax	277	$47K	2026-09-01	2026-09-02
Hughes Violetta CHIEF ACCOUNTING OFFICER · Common Stock · 2026-03-05	Grant	2.47K	—	2026-03-05	2026-09-02
Loeillot Olivier Chief Executive Officer · Common Stock · 2026-08-20	Exercise	5.43K	$769K	2026-08-20	2026-08-21
Loeillot Olivier Chief Executive Officer · Common Stock · 2026-08-20	Sell	5.43K	$977K	2026-08-20	2026-08-21
Loeillot Olivier Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-20	Exercise	5.43K	—	2026-08-20	2026-08-21
Garland Jason K CFO · Common Stock · 2026-07-16	Sell	530	$80K	2026-07-16	2026-07-17
EGLINTON MANNER CARRIE Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Pax Margaret Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in RGEN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

RGEN

Signal lifecycle

Recent news

Get daily signals & real-time alerts.